These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 30299265)

  • 81. Phenotype and genotype of polycystic ovary syndrome in Asia: Ethnic differences.
    Kim JJ; Choi YM
    J Obstet Gynaecol Res; 2019 Dec; 45(12):2330-2337. PubMed ID: 31588677
    [TBL] [Abstract][Full Text] [Related]  

  • 82. PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment.
    Morgante G; Darino I; Spanò A; Luisi S; Luddi A; Piomboni P; Governini L; De Leo V
    J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956124
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Vitamin D in the aetiology and management of polycystic ovary syndrome.
    Thomson RL; Spedding S; Buckley JD
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):343-50. PubMed ID: 22574874
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The value of the free androgen index depends on the phenotype of polycystic ovary syndrome - a single-centre experience.
    Ożga K; Krzyczkowska-Sendrakowska M; Hubalewska-Dydejczyk A; Gilis-Januszewska A; Ratajczak M; Ratajczak M; Chaykivska Z; Jach R
    Endokrynol Pol; 2019; 70(4):330-335. PubMed ID: 30938834
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR; Gargari BP; Farzadi L
    Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
    Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Metabolic and other effects of pioglitazone as an add-on therapy to metformin in the treatment of polycystic ovary syndrome (PCOS).
    Valsamakis G; Lois K; Kumar S; Mastorakos G
    Hormones (Athens); 2013; 12(3):363-78. PubMed ID: 24121378
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review.
    Saei Ghare Naz M; Ramezani Tehrani F; Behroozi-Lak T; Mohammadzadeh F; Kholosi Badr F; Ozgoli G
    Res Rep Urol; 2020; 12():179-185. PubMed ID: 32440514
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pathophysiological Effects of Contemporary Lifestyle on Evolutionary-Conserved Survival Mechanisms in Polycystic Ovary Syndrome.
    Parker J
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109585
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions.
    Emanuel RHK; Roberts J; Docherty PD; Lunt H; Campbell RE; Möller K
    Front Endocrinol (Lausanne); 2022; 13():1017468. PubMed ID: 36457554
    [TBL] [Abstract][Full Text] [Related]  

  • 92. AGEs-related dysfunctions in PCOS: evidence from animal and clinical research.
    Tatone C; Di Emidio G; Placidi M; Rossi G; Ruggieri S; Taccaliti C; D'Alfonso A; Amicarelli F; Guido M
    J Endocrinol; 2021 Sep; 251(2):R1-R9. PubMed ID: 34448729
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Potential Roles of mtDNA Mutations in PCOS-IR: A Review.
    Dong XC; Liu C; Zhuo GC; Ding Y
    Diabetes Metab Syndr Obes; 2023; 16():139-149. PubMed ID: 36760584
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Transgenerational transmission of reproductive and metabolic dysfunction in the male progeny of polycystic ovary syndrome.
    Risal S; Li C; Luo Q; Fornes R; Lu H; Eriksson G; Manti M; Ohlsson C; Lindgren E; Crisosto N; Maliqueo M; Echiburú B; Recabarren S; Petermann TS; Benrick A; Brusselaers N; Qiao J; Deng Q; Stener-Victorin E
    Cell Rep Med; 2023 May; 4(5):101035. PubMed ID: 37148878
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites.
    Chen W; Pang Y
    Metabolites; 2021 Dec; 11(12):. PubMed ID: 34940628
    [TBL] [Abstract][Full Text] [Related]  

  • 96. An overview on effects of micronutrients and macronutrients interventions in management of polycystic ovary syndrome.
    Saei Ghare Naz M; Jahanfar S; Ramezani Tehrani F
    Clin Nutr ESPEN; 2022 Dec; 52():218-228. PubMed ID: 36513457
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome.
    Scarfò G; Daniele S; Fusi J; Gesi M; Martini C; Franzoni F; Cela V; Artini PG
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740328
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Dietary Patterns and Polycystic Ovary Syndrome: a Systematic Review.
    Xenou M; Gourounti K
    Maedica (Bucur); 2021 Sep; 16(3):516-521. PubMed ID: 34925611
    [No Abstract]   [Full Text] [Related]  

  • 99. Traditional Persian Medicine and management of metabolic dysfunction in polycystic ovary syndrome.
    Hosseinkhani A; Asadi N; Pasalar M; Zarshenas MM
    J Tradit Complement Med; 2018 Jan; 8(1):17-23. PubMed ID: 29321985
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Reshaping the Gut Microbiota Through Lifestyle Interventions in Women with PCOS: A Review.
    Sivasankari R; Usha B
    Indian J Microbiol; 2022 Sep; 62(3):351-363. PubMed ID: 35974920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.